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Abstract
Background: The toxicity of released metallic particles generated in metal-on-metal (MoM) total hip arthroplasty
(THA) using cobalt chromium (CoCr) has raised concerns regarding their safety amongst both surgeons and the
public. Soft tissue changes such as pseudotumours and metallosis have been widely observed following the use of
these implants, which release metallic by-products due to both wear and corrosion. Although activated fibroblasts,
the dominant cell type in soft tissues, have been linked to many diseases, the role of synovial fibroblasts in the
adverse reactions caused by CoCr implants remains unknown. To investigate the influence of implants
manufactured from CoCr, the periprosthetic synovial tissues and synovial fibroblasts from patients with failed MoM
THA, undergoing a revision operation, were analysed and compared with samples from patients undergoing a
primary hip replacement, in order to elucidate histological and cellular changes.
Results: Periprosthetic tissue from patients with MoM implants was characterized by marked fibrotic changes,
notably an increase in collagen content from less than 20% to 45–55%, an increase in α-smooth muscle actin
positive cells from 4 to 9% as well as immune cells infiltration. Primary cell culture results demonstrated that MoM
synovial fibroblasts have a decreased apoptosis rate from 14 to 6% compared to control synovial fibroblasts. In
addition, synovial fibroblasts from MoM patients retained higher contractility and increased responsiveness to
chemotaxis in matrix contraction. Their mechanical properties at a single cell level increased as observed by a 60%
increase in contraction force and higher cell stiffness (3.3 kPa in MoM vs 2.18 kPa in control), as measured by
traction force microscopy and atomic force microscopy. Further, fibroblasts from MoM patients promoted immune
cell invasion by secreting monocyte chemoattractant protein 1 (MCP-1, CCL2) and induced monocyte
differentiation, which could also be associated with excess accumulation of synovial macrophages.
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Conclusion: Synovial fibroblasts exposed in vivo to MoM THA implants that release CoCr wear debris displayed
dramatic phenotypic alteration and functional changes. These findings unravelled an unexpected effect of the CoCr
alloy and demonstrated an important role of synovial fibroblasts in the undesired tissue reactions caused by MoM
THAs.
Keywords: Cobalt chromium debris, Synovial fibroblast, Inflammation, Fibrosis
Background
Soft tissue reactions develop in response to all total hip re-
placements, however between 2008 and 2015 in the UK,
92.5% of hip revision procedures involved metal-on-metal
(MoM) total hip arthroplasty (THA) implants [1], manu-
factured from a cobalt chromium alloy (CoCr). The for-
mation of pseudotumours, aseptic lymphocyte-dominated
vasculitis-associated lesion (ALVAL) and metallosis (often
defined as aseptic fibrosis and local necrosis) are believed
to be the sequelae of large amounts of CoCr metal parti-
cles and dissociated ions released from the hip bearing
surfaces due to both wear processes and corrosion [2–4].
Synovial tissues retrieved at the MoM revision surgery
have shown the presence of a large number of amorphous
particles predominantly composed of chromium and co-
balt [5–7]. The majority of these particles from the im-
plants are in the nano-sized scale and the severity of the
adverse tissue reactions is reported to be related with the
complexity of the particles and blood metal ion levels [7].
The spectrum of these tissue reactions is extensive and
ranges from small asymptomatic cysts to destructive peri-
prosthetic soft-tissue masses, which may lead to severe
symptoms of pain and ultimately implant failure [8]. The
integrity of the synovial lining is often impaired by inflam-
matory cell infiltrates (lymphocytes, macrophages, plasma
cells and giant cells), which indicate the extent of ALVAL
[9]. While immune cells play a key role in the initiation
and progression of the tissue reactions [1, 10], some evi-
dence suggests that chronic inflammation occurs because
of the activated fibroblasts, resulting in the inappropriate
survival and retention of immune cells within inflamed tis-
sue [11]. However, the role of stromal fibroblasts and tis-
sue/extracellular matrix (ECM) organisation in the
inflammatory response following exposure to cobalt metal
wear and corrosion products in vivo remains largely
unknown.
Previously, we reported that metal ions, particularly
cobalt, alter healthy human dermal fibroblasts in vitro
by stimulating contraction and the release of pro-fibrotic
signals from macrophages, thus leading to fibrotic reac-
tions and matrix remodelling [12]. To further investigate
whether this interaction between fibroblasts and im-
mune cells also occurs in vivo following exposure to
CoCr particulates and associated ions, we examined
ex vivo the properties of fibroblasts isolated from
periprosthetic synovial tissues from patients implanted
with a MoM (manufactured from standard CoCr alloy)
THA, retrieved during revision operations. To uncouple
the role of any underlying inflammatory condition, we
used a control group of synovial fibroblasts isolated from
patients undergoing a primary hip replacement oper-
ation. As soft tissue reactions have not been reported as
often in patients with either ceramic-on-polyethylene or
metal-on-polyethylene THA bearings [1], fibroblasts
from these patients were not investigated. We hypothe-
sise that the synovial fibroblasts retrieved at revision op-
erations would show altered mechanical and functional
properties that could be related to the released wear and
corrosion products from the bearing surfaces of the
MoM THAs, and could thereby stimulate inflammatory
responses in vitro. The implication of this study suggests
that synovial fibroblasts have a role in the in vivo inflam-
matory soft tissue reactions following MoM THA.
Materials and methods
Sample collection
Ethics approval and patient selection
Ethics approval [07/Q0401/25, West London Research
Ethics Committee] and written patient consent was ob-
tained for the use of tissue samples (synovial mem-
branes) removed during surgery. Tissue samples were
collected from patients (Table 1) undergoing either pri-
mary hip replacement surgery (Primary THA) or a revi-
sion surgery where a primary MoM hip implant had
been used (Revision THA). All tissue specimens were
anonymised. Patients with unilateral and bilateral total
hip replacements were included in this study, whilst pa-
tients with prostheses other than MoM, were excluded
from this study. The criteria for failed MoM implants in-
cluded unexplained pain, implant loosening and high co-
balt and chromium ion levels in the blood, as described
in Table 1. The original reason for surgery for the revi-
sion THAs would have been OA. The exclusion criteria
in this study were infection, mechanical instability or
prosthesis malalignment.
Tissue harvest and storage
Primary fibroblasts were isolated from biopsies obtained
from patients once the joint capsule was exposed during
surgery. Another part of the tissues used for histology
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was stored in 10% Neutral Buffered Formalin (Sigma,
UK) at room temperature before processing.
Histology
Fixed tissues were dehydrated through a series of graded
ethanol baths (70, 90%, absolute ethanol), cleared in a
xylene bath (Sigma, UK) and finally embedded in paraf-
fin and placed on ice at − 20 °C overnight. The tissue in
the wax blocks was trimmed and cut into 5 μm sections
(Accu-Cut® SRMTM 200 rotary microtome, Torrance,
CA, USA). Slides were deparaffinised by washing in 2
changes of xylene and graded ethanol baths (absolute
ethanol, 90, 70%). Antigen retrieval was performed to
unmask the antigenic epitope of the tissue sample by
boiling the deparaffinised sections in citrate buffer at
pH 6.0. Endogenous peroxidase activity was blocked by
incubating sections in 3% H2O2 solution (Sigma, UK) in
PBS at room temperature for 10 min followed by 2
rinses in PBS. To reduce background staining the sam-
ples were incubated with normal goat serum (5% in
PBS) to block nonspecific binding sites. After removing
the blocking buffer, 100 μl of rabbit polyclonal anti-type-
I collagen antibody (1:1000 in 1% goat serum in PBS,
Abcam, UK) or rabbit polyclonal anti-α-smooth muscle
actin (SMA) antibody (1:2000; Sigma-Aldrich, USA) was
added to the sections on the slides and incubated in a
humidified chamber at room temperature for 1 h, after
which the slides were washed twice in PBS. 100 μl of a
diluted biotinylated secondary antibody (in 1% goat
serum in PBS, Vector Laboratories, UK) was then
applied to the sections and incubated in a humidified
chamber at room temperature for 30 min, washed in
PBS, then incubated for 30 min with VECTASTAIN®
ABC Reagent (Vector Laboratories, UK). Samples were
washed and incubated in peroxidase substrate solution
(Vector Laboratories, UK) with positive staining visual-
ized by using a DAB Peroxidase (HRP) Substrate Kit
(Vector laboratories, UK).
Isolation and culture of synovial fibroblasts
Biopsy samples were collected in DMEM medium, then
transported on ice, and primary fibroblasts were isolated
within 6 h. The harvested tissues were transferred into a
10 cm tissue culture dish in DMEM medium using a ster-
ile forceps and finely minced into approximately 1mm3
pieces using sterile scalpels. The pieces of tissues were
placed in a 15ml centrifuge tube containing 10ml of di-
gestion solution (0.1% collagenase in DMEM medium,
Sigma, UK) and incubated at 37 °C under rotation for 2 h.
15ml DMEM medium was subsequently added to dilute
the collagenase which was passed through a 70 μm cell
strainer (BD Biosciences, UK) to obtain a single-cell sus-
pension. The cell suspension was centrifuged for 5min at
200 x g at room temperature, the supernatant was dis-
carded and the pellet resuspended in DMEM cell culture
medium (10% FBS and 1% P/S). Harvested cells were
counted and seeded at approximately 4000 cells/cm2 in a
T75 flask. The human synovial fibroblasts were cultured
at 37 °C and 5% CO2, with a first medium change 24–48 h
later. The medium was changed every 2–3 days.





Time from primary to revision (year) Reason for surgery
Primary THA 1 F 53 / OA
2 F 53 / OA
3 F 54 / OA
4 F 56 / OA
5 M 49 / OA
6 F 58 / OA
7 F 62 / OA
8 F 55 / OA
Revision THA 1 F 85 10 Painful hip with elevated metal ions
2 F 66 5 Painful hip
3 M 63 14 Painful hip
4 F 90 7 Trunionosis
5 M 75 6 Painful hip with elevated metal ions
6 M 75 11 Painful hip
7 F 56 9 Aseptic loosening
8 M 79 9 Elevated metal ions
(OA osteoarthritis)
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Cell metabolic activity measurement
Synovial fibroblast proliferation was measured using
CellTiter 96® Aqueous One Solution Cell Proliferation
Assay (Promega) according to the manufacturer’s in-
structions. Fibroblasts were cultured in 96-well tissue
culture plates at 5 × 103 cells/well over 72 h. Cell culture
supernatants were aspirated and 100 μL of serum-free
DMEM medium containing 10% CellTiter reagent was
added to each well. Plates were incubated for 2 h at
37 °C and the absorbance was read at 490 nm using an
Infinite F50 plate reader (Tecan, UK). Five replicates of
each exposure were tested and the entire assay was re-
peated in three separate experiments. The cell viability
was determined as a percentage of control cell viability.
Collagen contraction
A contraction assay was used to measure collagen con-
traction by fibroblasts. Fibroblasts (1 × 104 cells/ml) were
first mixed with 1.5 mg/ml neutralized rat tail collagen
solution (3 parts of 2 mg/ml collagen solution with 1
part DMEM medium). 0.5 ml fibroblast-containing colla-
gen solution was added to 24-well cell culture plates and
allowed to polymerize for 30 min at 37 °C. Then 0.5 ml
of serum-free cell culture medium was added and the
gels were incubated for 12 h. Following incubation, these
gels containing fibroblasts were gently detached from
the wells using fine straight and curved forceps. The
medium was aspirated and replaced with DMEM cell
culture media containing either 10% serum, PDGF-BB
(10 ng/ml, Peprotech, UK) or TGF-β1 (5 ng/ml, Pepro-
tech, UK). The gel contraction was recorded following
12 h of exposure to these media.
Mechanical properties measurement
Traction force measurement
Briefly, 22 mm coverslips (Corning, USA) were treated
with Hexamethyldisilazane (HMDS, VWR, UK), rinsed,
air dried and a gel solution of 5% containing acrylamide
(Biorad, UK), 0.25% bis-acrylamide (Biorad, UK), 0.05%
ammonium persulfate (10% APS, Sigma), 0.1% 1, 2-Bis
(dimethylamino) ethane (TEMED, Sigma, UK) and
carboxylate-modified beads (fluorescent red, diameter
0.2 μm, 1% v/V, ThermoFisher) was applied. After
polymerization, the gel was activated with heterobifunc-
tional cross-linker 1 mg/ml Sulfo-SANPAH (Sigma) and
thoroughly rinsed with distilled water. The gels were
then coated with type I rat tail collagen (0.2 mg/ml)
overnight. Fibroblasts were plated at a density of 3 × 104
cells/well in a serum-free DMEM and incubated over-
night at 37 °C and 5% CO2 in a humid incubator before
imaging (LS720 Microscope, Lumascope, UK). Bright-
field for cells and 525 nm for bead image stacks were ac-
quired at each position. After imaging, fibroblasts were
lysed with 1% SDS with the positions re-imaged. Five
different cells from each of 8 control samples and 8
MoM samples were analysed. A custom-built analysis
pipeline implemented in LabVIEW (National Instru-
ments, Austin, TX) was used to measure the traction
forces as previously described [13].
Atomic force microscopy (AFM)
The stiffness of fibroblasts was measured using Advanced
Quantitative Imaging mode on a JPK NanoWizard 4 sys-
tem in combination with an inverted microscope (Axio
Observer Z1, Zeiss). Cantilevers (HYDRA6R, AppNano,
UK) were calibrated by measuring the sensitivity against a
stiff polystyrene substrate, and then fitting the resonance
peak in the thermal noise spectrum to determine the
spring constant (approximately 0.08N/m). A ROI of
100 × 100 μm was selected to cover an entire cell. Indenta-
tions were performed in a format of 32 × 32 at a loading/
unloading speed of 50 μm/s, which minimized cell move-
ment during scanning without compromising the reso-
lution. All the AFM experiments were carried out at 37 °C
in FBS-free medium. Force-indentation curves were fur-
ther processed involving background subtraction, height
correction and fitting with a modified Hertzian model.
Collagen production
To measure the hydroxyproline produced by fibroblasts,
the culture medium was collected after 48 h of culture
and hydrolyzed in 6 N HCl for 24 h at 105 °C. The
amount of 4-hydroxy proline in the hydrolyzate was de-
termined at a wavelength of 570 nm on a microplate
reader (BMG Nova Star, BMG LABTECH) using the
conventional colorimetric method [14].
Chemokine profiling
The cell culture media was harvested after 48 h and
processed for profiling chemokines using the Proteome
Profiler Human Chemokine Array Kit (R&D system,
Minneapolis, MN), which detects a panel of 31 chemo-
kines (Table 2). The array membranes were reacted with
the mixture of conditioned media and the antibody
cocktail for 18 h at 4 °C. After 3 washes, they were briefly
incubated with secondary antibodies conjugated with
horseradish peroxidase (HRP). The membranes were
then exposed to HRP substrate for 30 min. The intensity
of the reaction was quantified using a BIO-RAD Chemi-
Doc MP Imaging System (Bio-Rad, UK); the pixel
densities on developed X-ray film were analysed using
Image Lab software (Bio-Rad, UK). The supernatants
were assayed for MCP-1 concentrations with a human
MCP-1 ELISA kit (Biolegend, UK).
Transwell migration assay
Monocyte migration was investigated using 6.5 mm
Transwell chambers with 8 μm pores (Costar, Corning,
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NY, USA). Briefly, 1 × 105 U937 monocytes in serum-
free DMEM medium were added to the upper chamber
of an insert. The lower chamber was filled with cell cul-
ture supernatant from fibroblasts cultured for 48 h to
encourage cell migration down the FBS chemotactic gra-
dient. After 12 h, cells that transmigrated to the bottom
well were collected and counted.
Fluorescence-activated cell sorting (FACS) analysis
After 24 h of serum withdrawal, the percentage of apop-
totic fibroblast were determined via FACS utilising a
FITC Annexin V Apoptosis Detection Kit with PI (Biole-
gend, UK). The collected cell suspensions were trans-
ferred to FACS tubes (BD Biosciences; Oxford, UK),
centrifuged for 5 min at 350 x g and the supernatant as-
pirated. Cell suspensions were washed twice with cold
cell staining buffer (Biolegend, UK), and then resus-
pended in Annexin V Binding Buffer at a concentration
of 0.5 × 107 cells/ml. 100 μl of cell suspension was trans-
ferred to a 5 ml test tube and 5 μl of FITC Annexin V
with 10 μl of Propidium Iodide Solution was added. The
mixture of cells and staining reagent was allowed to in-
cubate for 15 min at room temperature in the dark prior
to analysis with flow cytometry. Stained cells were
washed and re-suspended in 200 μl of PBS and analysed
using a BD ACCURI C 6 flow cytometer (Biosciences,
USA) and FlowJo software (TreeStar, USA).
Co-culture of U937 monocytes and synovial fibroblasts
Porous plasma-treated polycarbonate inserts (pore size:
0.4 μm, Transwell, Corning) were used for non-contact
co-culture of fibroblasts and U937 monocytes. MoM
and control synovial fibroblasts were added to the top of
the Transwell® insert at 2.5 × 104cells/well and U937
monocytes were cultured at 5 × 104cells/well in 24-well
tissue culture plates providing a co-culture within each
well. The increase in the differentiation of U937 mono-
cytes was quantified by counting the cells that floating in
the medium collected from each well of tissue culture
plates by 0 h, 12 h and 24 h of co-culture.
Image analysis
Images were acquired on an upright microscope (Nikon
Eclipse). For image quantification, the mean percentage
area positive for 10 randomly selected high powered
fields (× 10 magnification) was calculated using ImageJ
analysis software as described previously [15].
Data analysis and statistics
All data were expressed as the mean + SEM of at least
three independent experiments. The statistical differ-
ences between groups were analysed with Student t-test
(SPSS Inc., Chicago, IL, USA). A value of p < 0.05 was
considered statistically significant.
Results
Tissue remodelling of patients with metal-on-metal hip
implants
A gross morphological change to the periprosthetic tissue
was observed in tissues collected from patients with failed
MoM implants. The biopsies were generally denser, pig-
mented and contained fibrotic regions (Fig. 1a). At the
microscopic level metal wear or corrosion products in
some of the MoM cases were observed, which appeared a
dark-grey or green morphology (Fig. 1a) as previously re-
ported [16]. To determine the level of a fibrotic change,
we assessed the collagen deposition. The control tissues
obtained at primary THA operations were characterised
by a wide distribution of fat cells (adipocytes) and approxi-
mately 20% collagen content as determined by Picrosirius
Red staining (Fig. 1b,e) and more specifically collagen type
I (Fig. 1c,f). Elevated levels of collagen were observed in
the MoM tissues, with approximately 55% positive stain-
ing for collagen and 45% for collagen type I. We further
observed a significant increase in the number of myofibro-
blasts in the MoM tissues from less than 4% to nearly 9%
(Fig. 1d,g) as determined by the positive staining for α
-SMA.
MoM fibroblast are more resistant to apoptosis
The balance between cell proliferation and apoptosis
plays a key role in tissue homeostasis. First, we investi-
gated whether the increased matrix deposition in tissue
Table 2 Chemokines detected with the Proteome Profiler Human Chemokine Array
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is due to an increase in proliferative capacity of synovial
fibroblasts exposed to metal products from MoM im-
plants. We found that ex vivo MoM fibroblasts showed
the same proliferative capacity as control synovial fibro-
blasts over 72 h of culture (Fig. 2a). It has been reported
that fibroblast survival could be altered under certain
pathological condition in a manner of reduced cell
apoptosis, which contributes to the development and
maintenance of fibrosis [17]. Although no significant dif-
ference in the proliferative ability was identified between
primary and MoM fibroblasts, MoM synovial fibroblasts
showed reduced apoptosis rates following serum with-
drawal (Fig. 2b) compared with the control cells. Primary
(Fig. 2c) and MoM fibroblast (Fig. 2d) survival was de-
termined by serum withdrawal-induced apoptosis, ana-
lysed by an Annexin V-FITC/PI assay via FACS.
According to the results shown, after 24 h of serum
withdrawal, the percentage of apoptotic cells for MoM
fibroblasts were approximately 6%, compared to nearly
14% for the control fibroblasts. These data suggest that
MoM fibroblasts are more resistant to apoptosis, which
may partially explain their accumulation and tissue re-
modelling in the patients with CoCr alloy implants.
Matrix remodelling by human synovial fibroblasts
To elucidate the in vivo tissue alterations in tissue dens-
ity and matrix deposition, the isolated synovial fibro-
blasts were examined ex vivo for matrix production. We
measured the hydroxyproline content as a surrogate for
collagen. A statistically significant increase in production
of pro-collagen by MoM synovial fibroblasts was ob-
served when compared to the control synovial
Fig. 1 Synovial tissues from primary THA patients and patients with metal-on-metal THA implants. a Macroscopic evaluation of synovial membrane
isolated from primary and revision MoM THA implants. Scale bar indicates 50 μm. b Collagen visualized by picrosirius red and c collagen I visualized by
immunohistochemistry staining with quantification showed in e and f. d α-SMA positive fibroblasts in synovial membrane tissue with quantification
shown in g. Scale bar indicates 200 μm in (b-d). Data was obtained from 8 primary THA and 8 MoM tissue samples. For each slide/patient, 10 random
fields were imaged for analysis. Bars represent mean + SEM; unpaired t-test, ** p < 0.01, *** p < 0.001
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fibroblasts from primary THAs (Fig. 3a). This suggests
that synovial fibroblasts isolated from tissues surround-
ing a MoM implant which requires revision, but has
been in use, releasing metal and ionic debris for 5–14
years, have enhanced matrix production ability and
retain that capability ex vivo in the absence of the metal
stimulation. To investigate whether the MoM synovial
fibroblasts have greater capability to deform matrix,
which is an important aspect of pro-fibrotic alteration,
their contractility potential was analysed. An in vitro
Fig. 2 Proliferation and apoptosis of primary and MoM fibroblast. a Proliferation of primary and MoM fibroblasts over 72 h measured by MTS assay. Apoptosis
of primary and MoM fibroblast induced by serum withdrawal. b Quantification of apoptotic cells of primary and MoM fibroblasts. Data was from 3 independent
experiments using fibroblasts from each primary and MOM patient; unpaired Student’s t-test; *p <0.05. Representative cell apoptosis results of primary (c) and
MoM (d) fibroblasts from each patient assessed by Annexin V-FITC/PI assay via FACS
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collagen gel contraction assay was performed in various
conditions, including serum-free conditions and in the
presence of serum (10% FBS), PDGF (10 ng/mL), TGF-
β1 (5 ng/mL) and IL-1β (10 ng/mL). In the serum-free
condition, the contractility of MoM and control synovial
fibroblasts was comparable (Fig. 3b), while in the pres-
ence of serum the contractility of MoM synovial fibro-
blasts was significantly increased (p < 0.05). When
mimicking inflammatory conditions, by adding PDGF or
TGFβ, the MoM fibroblast contractility further increased
to 56.9 ± 3.8% (from 31.7 ± 3.1%) in the presence of
PDGF (p < 0.01) and to 59.5 ± 3.7% (from 40.3 ± 2.9%) in
the presence of TGF-β (p < 0.01) (Fig. 2c-e). While IL-1β
have not obvious effects on the contractility of both
MoM and control synovial fibroblasts. These results
suggest that MoM synovial fibroblasts displayed a dis-
tinctive bio-mechanical response to associated inflam-
matory signalling.
MoM-induced alterations of fibroblast mechanical
properties
The contractility of cells is regulated by their mechanical
properties. Previously, we showed that cobalt exposure
affects cell elastic modulus and contractile force of hu-
man dermal fibroblasts [12]. To study the link between
the increased contractility of MoM synovial fibroblasts
and alterations in their mechanical properties, we per-
formed Traction Force Microscopy and Atomic Force
Microscopy. First, we measured the traction forces of
resting synovial fibroblast (following 24 h of serum
Fig. 3 Synovial fibroblasts from patients with MoM implant display increased ECM matrix production and contractility. a Collagen released by cultured
synovial fibroblasts into the cell culture medium after 48 h. Bars represent mean + SEM. b-f Fibroblasts from MoM and primary THA were embedded in
a collagen matrix and contraction was measured after 48 h, in serum-free medium (b), medium with 10% serum (c) or with cytokines (10 μg/ml PDGF
(d), 5 μg/ml TGF-β1 (e) and 10 ng/mL IL-1β (f). Shown is mean ± SEM for gel contraction after 48 h of culture. Each individual data point is the average
of 3 independent experiments using fibroblasts from each patient. * p < 0.05, ** p < 0.01
Xu et al. Particle and Fibre Toxicology           (2020) 17:42 Page 8 of 13
starvation). A significant increase, of nearly 60%, in cel-
lular traction forces (p < 0.05) was observed in MoM
synovial fibroblasts when compared to the control
(Fig. 4a and b). Cell stiffness is closely associated with
cell behaviour and the alterations in cell traction forces
could be coupled with alterations in cell elastic modulus,
which has been suggested as an indicator of cytoskeleton
rearrangement [18]. We observed that the cell elastic
modulus measured with AFM (Fig. 4c and d) was also
significantly higher (3.33 ± 0.65 KPa) in MoM synovial fi-
broblasts compared with the control (2.18 ± 0.74 KPa) as
shown in Fig. 4e.
MoM fibroblasts promote immune cell invasion and
differentiation
As reported in the previous section, growth factors re-
leased by immune cells drive the contractile activity of
MoM synovial fibroblasts. One of the key immune cells
activated by cobalt released from CoCr implants (MoM)
are CD68+ macrophages, which release pro-fibrotic sig-
nals and enhance the fibrotic response of fibroblasts [4].
The histological analysis of the tissue biopsies showed a
significant increase in CD68+ macrophages in MoM tis-
sues (Fig. 5a). However, whether the MoM synovial
fibroblast release pro-inflammatory signals to recruit
macrophages, is unclear. To study the pro-inflammatory
properties of MoM synovial fibroblasts, a migration
assay was performed. The U937 monocyte migration
was significantly enhanced in the presence of cell culture
supernatants from MoM fibroblasts (Fig. 5b). By exam-
ining the chemokine profile of the supernatants (Fig. 5c),
a significant elevation in MCP-1 (monocyte chemo-
attractant protein 1) was observed in the MoM fibroblast
cell culture supernatant compared to the control (Fig.
5d&e). This suggests that MoM fibroblasts could po-
tentiate the tissue immune response through the
Fig. 4 Contractile forces and cell stiffness of fibroblasts from patients during primary THA and at revision from a MoM THA. a Bright field images
of individual cell (i) and corresponding stress magnitude maps (ii); b Quantification of cellular contractile force of fibroblasts from the cells of
individual groups; n = 40 for each group (each data point represents the mean value of 5 cells analysed for each patient). c Schematic of AFM
setup for measuring cell stiffness. d Image showing the AFM cantilever and synovial fibroblasts. e Quantification of cell stiffness for primary and
MoM fibroblasts; n = 40 (each data point represents the mean value of 5 cells analysed for each patient); unpaired Student’s t-test. *p < 0.05
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secretion of MCP-1, thereby enhancing monocyte infil-
tration. Also, to test the effect of MoM fibroblasts on
monocyte differentiation, fibroblasts from MoM and
control patients were co-cultured with U937 human
monocytes. It could be noticed that both MoM and con-
trol synovial fibroblasts induced monocyte differenti-
ation into macrophages, as indicated by increased
cellular adhesion to the substrate with the number of
floating U937 monocytes were significantly lower com-
pared to the untreated cells at the 24 h time points (Fig.
5g). Furthermore, the number of floating U937 mono-
cytes decreased to a greater extent in the presence of
MoM synovial fibroblasts compared with control fibro-
blasts (Fig. 5g). Therefore, these results indicated the
Fig. 5 MoM fibroblast recruit and promote monocytes differentiation. a Immuno-histochemical staining of macrophage infiltration in synovial
tissue from a MoM patient (magnification × 100). b Migrated monocytes in harvested medium from primary and MoM fibroblasts. c Chemokines
detected using Human Chemokine Array. d Signal intensity of measurable chemokines of from (c) showing mean ± SEM. e Quantification of MCP-
1 secreted in the cell culture medium, showing mean + SEM. Data was from 3 independent experiments using fibroblasts from all primary and
MoM patients; unpaired Student’s t-test; *p < 0.05, **p < 0.01. f Images indicated that co-culture with synovial fibroblast promoted monocyte
differentiation into adherent macrophages. Scale bar = 10 μm. g The increase in monocyte differentiation was quantified by counting the floating
cells. Data shown as mean + SEM; n = 3; unpaired Student’s t-test; *p < 0.05, **/##p < 0.01
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presence of higher amount of pro-inflammatory factors
from MoM fibroblasts that could promote the invasion
and differentiation of human monocyte.
Discussion
Despite being one of the most significant issues in the
field of total hip arthroplasty, the precise mechanisms
associated with adverse tissue reactions to wear debris
generated in patients following the implantation of a
MoM implant (which generates CoCr particles and dis-
sociated ions in use) responsible for the devastating fail-
ure of these implants, remains poorly understood. Many
cell lines have previously been used to investigate the ef-
fects of CoCr wear particles and ions in vitro including
macrophages, lymphocytes and osteoblasts. In vitro
studies have revealed that CoCr metallic debris and ions
trigger the release of an array of proinflammatory media-
tors from macrophages [19–21], such as transforming
growth factor α (TGF-α), macrophage colony-
stimulating factor (M-CSF), platelet-derived growth fac-
tor (PDGF) and epidermal growth factor (EGF). Cobalt
has also been known to promote intracellular reactive
oxygen species formation that lead to a wide range of
deleterious effects and irreversible damage.
Fibroblasts are one of the central participants for
wound healing and inflammation. They play a positive
role in promoting the recovery of functional tissue but
equally are capable of driving it towards chronic inflam-
mation, fibrosis or even tissue necrosis depending on
their exposure to biochemical cues [19]. It has also been
reported that fibroblasts, one of the most active tissue
resident mesenchymal cells, may display site or disease-
specific phenotypes after exposure to inflammatory sig-
nals, which could induce a dysregulated homeostatic bal-
ance of extracellular environment [22]. This motivated
the present study, in which in vitro assays were applied
to characterise some of the key features of primary hu-
man synovial fibroblasts and investigate their contribu-
tion to the tissue response and disease progression.
The findings of this study demonstrated that synovial
tissues from patients undergoing revision surgery due to
the failure of the MoM device were macroscopically and
histologically different from tissues isolated from pa-
tients undergoing primary THA surgery, with evidence
of extensive tissue remodelling characterised by replace-
ment of adipocytes with dense areas of collagen (Fig. 1a-
c). In addition, we observed enhanced activation of syn-
ovial fibroblast activation with a significant increase in
the number of myofibroblasts in the tissues (Fig. 1d). Fi-
broblasts are the primary cell type responsible for ECM
proteins synthesis to build up the connective tissue.
Moreover, they promote ECM remodelling via transmit-
ting force to contract and compact the surrounding
matrices to achieve tensional homoeostasis, which have
a significant impact on other cells’ behaviour [23]. Our
data demonstrated that stimulated fibroblasts isolated
from patients undergoing a MoM THA revision were
more efficient at contracting collagen matrix and were
also more responsive to biochemical stimuli involving
cytokines and growth factors (Fig. 3). They were also
found to display altered cell force responses compared
to the control primary cells (Fig. 4). Disruption of the
balance between cell proliferation and apoptosis could
affect tissue homeostasis. The enhanced survival of
MoM fibroblasts when exposed to apoptotic signal (Fig.
2) also confirmed the alteration of fibroblasts phenotype
and undesired cellular response after exposure to CoCr
metal wear and corrosion products.
Previous research has largely focused on the cytotoxic
effects of CoCr alloy products on fibroblasts ex vivo,
with little attention being paid to their influence on local
tissue homeostasis in vivo [24–26]. Indeed recent evi-
dence has suggested that the deposition of ECM, pro-
duced by fibroblasts as well as tissue mechanics play a
vital role in the regulation of the inflammatory process
[27]. For instance, stiffer tissue substrates may enhance
immune cell invasion and the release of pro-
inflammatory cytokines by macrophages [28, 29]. In
addition to their structural role in shaping the micro-
environment, fibroblasts also modulate immune
responses via their production of cytokines and chemo-
kines [23].
Periprosthetic synovial tissues from patients with
MoM THA implants at the revision operation, were
characterized by intensive immune cells infiltration.
However, the key stimulus of driving the immune cell
invasion is largely unknown. MCP-1/CCL2 is one of the
critical chemokines that mediates migration and infiltra-
tion of monocytes and macrophages during inflamma-
tory response. In vivo and in vitro studies suggest that
MCP-1 plays a direct role in the development of many
fibrotic lesion by affecting fibroblasts behaviour [30–32].
In this study, we found that fibroblasts surrounding
failed MoM THA revision patients may play an indis-
pensable role in the recruitment of immune cells by se-
creting MCP-1, which enhances chemotactic migration
of monocytes and exacerbate inflammatory reactions
(Fig. 5). Our results also indicated that MoM fibroblasts
produce stimulating factors to promote the differenti-
ation of monocytes, thus potentiating the pathogenic
persistence and retention of macrophages in the synovial
tissues surrounding MoM implants. Recent studies have
reported non-MoM THAs, such as metal-on-
polyethylene (MoP), to be presenting adverse tissue re-
sponses similar to the MoM THAs. An adverse response
to MoP implants, such as the formation of pseudotu-
mours, may still be linked to the release of cobalt ions
from the metal head [33–35], albeit at a lower level. This
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suggests that any wear/corrosion debris containing co-
balt (nano) particulates or ions, may have a detrimental
influence on the hip tissue microenvironment.
Overall, we have shown that synovial fibroblasts ex-
posed to MoM THAs in vivo which require revision,
undergo phenotypic alteration which is associated with
dramatic functional changes that can be observed
ex vivo. The response to an inflammatory lesion involves
a complex interplay of diverse cellular and tissue ele-
ments that restrain tissue invasion and ultimately estab-
lish normal tissue integrity [36]. Instead of being a
passive player in the immune system, fibroblasts actively
define the organisation of tissue microenvironments and
modulate cell activities by conditioning the local cellular
and cytokine microenvironment [22, 37]. The inappro-
priate activation and accumulation of fibroblasts stimu-
lated by wear debris from failing MoM implants could
prevent the resolution of acute inflammation thereby
leading to chronic, persistent inflammation.
Conclusions
This study unravels the distinctive influence of MoM
total hip arthroplasties, which release CoCr wear and
corrosion debris in the form of particles and related
ions, on the fibroblast phenotype and their interplay
with immune cells (Fig. 6). Synovial fibroblasts exposed
to MoM THAs in vivo displayed dramatic phenotypic al-
teration and functional changes. These findings suggest
direct in vivo impact of failing MoM THAs on the syn-
ovial fibroblasts and local tissue homeostasis.
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